EHS has completed the new on line Introduction to Laboratory Safety Course, this course replaces the monthly classroom offerings and removes any remaining barriers to full compliance by anyone working in a DC laboratory specifically undergraduates with class conflicts.
Introduction to Laboratory Safety on line course
Radiation Safety Classroom Training - Contact EHS 646-1762
Dartmouth College's Institutional Biological Safety Committee (IBC) provides oversight and review of the College’s biological safety program. It serves as an advisory board to the research community at Dartmouth on biological safety and recombinant DNA. Committee functions include those designated for the IBC in the NIH Guidelines for Research Involving Recombinant DNA Molecules. The IBC meets regularly and meetings are open to the public. Please contact Dr. Brian J. O'Shea for additional information.
The research review process by the IBC is conducted in the step-wise fashion above, starting with the submission of research information by the PI using the online registration system BioRAFT.
Submit your research to the IBC (via EH&S) All information pertaining to biological agent usage, rDNA technology, animal research protocols, human source material, viral vector usage, and personnel invovled with the research should be updated whenever there is a change in the research focus. *Remember* As per the NIH Guidelines for rDNA research, "Principal Investigator is responsible for full compliance with the NIH Guidelines in the conduct of recombinant or synthetic nucleic acid molecule research. The Principal Investigator is responsible for ensuring that the reporting requirements are fulfilled and will be held accountable for any reporting lapses."
Please refer to the Investigator Responsibilities from the NIH Guidelines for more information.
EH&S Review EH&S will review your research information and conduct a risk assessment based upon the information submitted. Any questions/problems/concerns will be directed back to the PI for clarification. Once all aspects of the risk assessment have been satisfied by EH&S, your research will be reviewed by the IBC committee.
IBC Committee Review The IBC will review the research information submitted through BioRAFT and discuss the safety and regulatory aspects of the research project. Discussion topics include, nature of experimentation, location, rDNA aspects, training requirements fulfilled by research staff, past laboratory inspection record, etc. If it is warranted, researchers can be invited to present their research protocols to the IBC committee.
Decision Letter Sent to PI Once the IBC has made a decision regarding the research project reviewed, a decision letter will be sent to the PI from the Biological Safety Officer and the Chair of the IBC. This decision letter should be retained for your records.
Conduct Research Once an approval letter has been received from the IBC, only then can the proposed research begin.
The Dartmouth College IBC bylaws cover all of the working procedures for review of biological research and oversight authorities of the committee. Please use the following link to download a copy fo the Dartmouth IBC ByLaws.
The Dartmouth College Institutional Biosafety Committee - Subcommittee for Clinical Gene Transfer (IBC-SCGT) is a multidisciplinary committee charged with the review of clinical protocols involving gene related therapies.
More information on the Subcommittee for Clinical Gene Transfer
Surachai Supattapone, M.D., Ph.D., D.Phil., Chair/Biochemistry
Brian J. O'Shea, Ph.D., Biological Safety Officer, Environmental Health & Safety
Kirk, J. Maurer, DVM, Attending Veterinarian, Center for Comparative Medicine and Research
Sherrie Read, Office of Sponsored Projects
Alexandra Howell, Ph.D., V.A. Medical Center
Thomas Jack, Ph.D., Biological Sciences
Bert Hennessy, Hanover Fire Department/Community Representative
Elizabeth Bankert, MA, Assistant Provost/Human Subjects Protection Official
Karen Huyck Ph.D, MD, MPH, Medicine/Occupational Medicine
Géza Fejes-Tóth, D.M.D., Physiology
R. Mako Saito, PH.D., Genetics
Deborah A. Hogan, Ph.D., Micro/Immuno
Robin Oertel, Post-Approval Compliance
Brent Berwin, Ph.D., Micro/Immuno
